Candida nivariensis: Identification strategy in mycological laboratories

J Mycol Med. 2020 Dec;30(4):101042. doi: 10.1016/j.mycmed.2020.101042. Epub 2020 Aug 28.

Abstract

Candida nivariensis is a cryptic fungal species classified within the Candida glabrata complex. It was described for the first time in 2005 by the means of DNA sequencing. We report a rare case of C. nivariensis deep-seated infection occurring in a 77-year-old man hospitalized for cysto-prostatectomy. Phenotypic testing based on the direct examination and the macroscopic features of the in vitro culture initially suggested C. glabrata species, while MALDI-TOF mass spectrometry enables correct identification. The isolate was found resistant to fluconazole, like in almost 20% of the reported cases. Herein, we present our practical strategy to reliably characterize this rare cryptic species. To date, MALDI-TOF mass spectrometry-based analysis showed very good results for such a purpose.

Keywords: Antifungal resistance; Candida bracariensis; Candida glabrata; Candida nivariensis; Candidemia; Candiduria.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma of Lung / complications
  • Adenocarcinoma of Lung / immunology
  • Adenocarcinoma of Lung / microbiology
  • Aged
  • Candidemia / etiology
  • Candidemia / microbiology*
  • Carcinoma, Transitional Cell / microbiology
  • Carcinoma, Transitional Cell / pathology
  • France
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / immunology
  • Lung Neoplasms / microbiology
  • Male
  • Microbial Sensitivity Tests
  • Mycological Typing Techniques / methods
  • Recurrence
  • Saccharomycetales / classification*
  • Saccharomycetales / isolation & purification*
  • Urinary Bladder Neoplasms / microbiology
  • Urinary Bladder Neoplasms / pathology
  • Urothelium / pathology

Supplementary concepts

  • Candida nivariensis